Injectable vaccine to prevent re-emergence of polio launched

The vaccine will be administered in addition to polio drops to double the protection

Image via Shutterstock.
<a href="http://www.shutterstock.com/pic-290126924.html" target="_blank">Image</a> via Shutterstock.
Press Trust of India New Delhi
Last Updated : Nov 30 2015 | 2:22 PM IST
An injectable vaccine to prevent re-emergence of polio was launched today by the government and it will be administered in addition to polio drops to double the protection from the deadly virus which has chances of coming back.

The Inactivated Polio Vaccine (IPV) will be introduced in the routine immunisation programme of the government to do away with the risk of re-introduction of the disease.

Health Minister JP Nadda said that though India was certified polio-free on March 27, 2014, the battle against polio is not over yet.

Also Read

"The virus is still active in our neighboring countries -- Pakistan and Afghanistan. Cases of polio still happen there. So the risk of re-introduction of the disease remains, particularly through importation from these endemic countries," he said.

"We are there to give them all kinds of support including technical, experience or vaccine-related assistance. But we will have to be vigilant till the virus is eradicated globally," Nadda said at a function here to launch the vaccine.

"To ensure that our children are doubly protected from polio, the IPV is being introduced into the routine immunisation programme," he said

In the first phase, the IPV injection is being introduced in six states -- Assam, Bihar, Uttar Pradesh, Gujarat, Madhya Pradesh and Punjab.

However, the children will continue to receive OPV (polio drops) dose under routine immunisation and in pulse polio campaigns till they are 5 years of age.

"Even after receiving the IPV vaccine with the third dose of OPV (polio drops), the children must continue to receive OPV doses under routine immunisation and in pulse polio campaigns till they are five years of age," Health Secretary B P Sharma said.

He said with the elimination of Type 2 polio from the country, the government is shifting from tOPV vaccine to bOPV vaccine in April 2016 and the introduction of new vaccine IPV in the immunization programme will reduce the risk associated with the shift.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 30 2015 | 1:42 PM IST

Next Story